Your browser doesn't support javascript.
loading
Mepolizumab Is an Effective Option in Severe Eosinophilic Asthma Regardless of Baseline Features: Single-Center Real-Life Data.
Özdel Öztürk, Betül; Yavuz, Zeynep; Eraslan, Dilek; Mungan, Dilsad; Demirel, Yavuz Selim; Aydin, Ömür; Sin, Betül Ayse; Bavbek, Sevim.
Afiliação
  • Özdel Öztürk B; Division of Immunology and Allergic Diseases, Department of Chest Diseases, Ankara University School of Medicine, Ankara, Turkey.
  • Yavuz Z; Department of Biostatistics, Ankara University School of Medicine, Ankara, Turkey.
  • Eraslan D; Division of Immunology and Allergic Diseases, Department of Chest Diseases, Ankara University School of Medicine, Ankara, Turkey.
  • Mungan D; Division of Immunology and Allergic Diseases, Department of Chest Diseases, Ankara University School of Medicine, Ankara, Turkey.
  • Demirel YS; Division of Immunology and Allergic Diseases, Department of Chest Diseases, Ankara University School of Medicine, Ankara, Turkey.
  • Aydin Ö; Division of Immunology and Allergic Diseases, Department of Chest Diseases, Ankara University School of Medicine, Ankara, Turkey.
  • Sin BA; Division of Immunology and Allergic Diseases, Department of Chest Diseases, Ankara University School of Medicine, Ankara, Turkey.
  • Bavbek S; Division of Immunology and Allergic Diseases, Department of Chest Diseases, Ankara University School of Medicine, Ankara, Turkey.
Int Arch Allergy Immunol ; 183(5): 526-538, 2022.
Article em En | MEDLINE | ID: mdl-34915496
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Eosinofilia Pulmonar / Asma / Antiasmáticos Tipo de estudo: Observational_studies Limite: Adult / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Eosinofilia Pulmonar / Asma / Antiasmáticos Tipo de estudo: Observational_studies Limite: Adult / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article